Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
STROKE | STROKE Altmetrics Articles 2019
04/02/2020 | Stroke Trending Topics for March 2020
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation
03/09/2020 | Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with high morbidity, mortality and healthcare usage.
Epi Lifestyle 2020 Science News
03/03/2020 | AHA Science News: Exclusive interviews, study results and more from Epidemiology and Prevention/Lifestyle 2020 Scientific Sessions in Phoenix, Arizona
JAHA Conference Reads| EPI Lifestyle 2020
03/02/2020 | JAHA Conference Reads for EPI Lifestyle 2020
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.